Two existing prediction models are sufficiently accurate to guide decisions about the selection and interpretation of subsequent diagnostic tests in patients with SPNs, although clinicians should also consider the prevalence of malignancy in their practice setting when choosing a model.
No takes yet. Share an insight, caveat, or question.
Schultz et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: